Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Accounts Payables (2023 - 2025)

Astera Labs has reported Accounts Payables over the past 3 years, most recently at $42.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 57.37% year-over-year to $42.4 million, compared with a TTM value of $42.4 million through Dec 2025, up 57.37%, and an annual FY2025 reading of $42.4 million, up 57.37% over the prior year.
  • Accounts Payables came in at $42.4 million for Q4 2025, up from $25.8 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $42.4 million in Q4 2025 to a low of $6.3 million in Q4 2023.
  • Median Accounts Payables over the past 3 years was $25.8 million (2025), compared with a mean of $23.0 million.
  • The sharpest move saw Accounts Payables surged 324.78% in 2024, then skyrocketed 39.14% in 2025.
  • Over 3 years, Accounts Payables stood at $6.3 million in 2023, then surged by 324.78% to $26.9 million in 2024, then surged by 57.37% to $42.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's Accounts Payables are $42.4 million (Q4 2025), $25.8 million (Q3 2025), and $31.6 million (Q2 2025).